£2.9M
The Norwich-based drug discovery startup emerged from stealth with backing from SynBioVen, Start Codon, UKI2S, Twin Path Ventures, Wren Capital, angels, and Innovate UK.
HotHouse Therapeutics
HotHouse Therapeutics develops sustainable pharmaceutical compounds using an AI-optimised plant-based chemistry platform.
£2.9MTotal raised
HotHouse Therapeutics is a drug discovery platform company that develops sustainable pharmaceutical compounds through AI-optimised plant-based chemistry. The Norwich-based startup creates scalable molecules to transform modern medicine and address critical supply chain dependencies.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from HotHouse Therapeutics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
David Sheppard
CEO
David is chief executive officer at HotHouse Therapeutics and an independent director at RevoNA Bio, following previous leadership roles at Entact Bio.
LinkedInAO
Anne Osbourn
Professor